Mice Lacking ??-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System, Neuron, vol.25, issue.1, pp.239-252, 2000. ,
DOI : 10.1016/S0896-6273(00)80886-7
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains, Archives of Neurology, vol.67, issue.12, pp.1464-1472, 2010. ,
DOI : 10.1001/archneurol.2010.198
Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model, PLoS ONE, vol.20, issue.2, 2013. ,
DOI : 10.1371/journal.pone.0061700.s005
Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy, Journal of Neuroscience, vol.32, issue.46, pp.16503-16509, 2012. ,
DOI : 10.1523/JNEUROSCI.0209-12.2012
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol. Histopathol, vol.12, pp.25-31, 1997. ,
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra, Neurobiology of Disease, vol.65, pp.69-81, 2014. ,
DOI : 10.1016/j.nbd.2014.01.011
URL : https://hal.archives-ouvertes.fr/hal-01112500
Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease, Movement Disorders, vol.349, issue.10, pp.1481-1484, 2007. ,
DOI : 10.1002/mds.21399
The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance, Autophagy, vol.269, issue.11, pp.1801-1817, 2013. ,
DOI : 10.1093/hmg/ddl131
Oxidative stress and autophagy: the clash between damage and metabolic needs, Cell Death and Differentiation, vol.942, issue.3, pp.377-88, 2015. ,
DOI : 10.1038/nrm3735
ER stress inhibits neuronal death by promoting autophagy, Autophagy, vol.267, issue.6, pp.915-926, 2012. ,
DOI : 10.1111/j.1471-4159.2008.05217.x
URL : https://hal.archives-ouvertes.fr/ensl-00807628
Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of ??-Synuclein and LRRK2 in the Brain, Journal of Neuroscience, vol.32, issue.22, pp.7585-7593, 2012. ,
DOI : 10.1523/JNEUROSCI.5809-11.2012
Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map, Molecular Neurobiology, vol.27, issue.Suppl 1, pp.88-102, 2014. ,
DOI : 10.1007/s12035-013-8489-4
Genetics and iron in the systems biology of Parkinson???s disease and some related disorders, Neurochemistry International, vol.62, issue.5, pp.637-652, 2013. ,
DOI : 10.1016/j.neuint.2012.11.015
PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death, Molecular Cell, vol.33, issue.5, pp.627-638, 2009. ,
DOI : 10.1016/j.molcel.2009.02.013
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress, Proceedings of the National Academy of Sciences, vol.105, issue.32, pp.11364-11369, 2008. ,
DOI : 10.1073/pnas.0802076105
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1, Nature Cell Biology, vol.278, issue.2, pp.119-131, 2010. ,
DOI : 10.1038/ncb2012
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model, Proc. Natl. Acad. Sci. U S A, pp.4016-4025, 2013. ,
DOI : 10.1073/pnas.1309143110
Oxidative stress and the pathogenesis of Parkinson's disease, Neurology, vol.47, issue.Issue 6, Supplement 3, pp.161-70, 1996. ,
DOI : 10.1212/WNL.47.6_Suppl_3.161S
Inhibition of mitochondrial fusion by ??-synuclein is rescued by PINK1, Parkin and DJ-1, The EMBO Journal, vol.1193, issue.20, pp.3571-3589, 2010. ,
DOI : 10.1038/emboj.2010.223
Controlling the mass action of alphasynuclein in Parkinson's disease, 2008. ,
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4, MPTP) and oxidative stress. Proc. Natl. Acad. Sci. USA, pp.6-5215, 2003. ,
MPTP-induced parkinsonism in human and nonhuman primates -clinical and experimental aspects, Acta Neurol Scand, vol.100, pp.49-54, 1984. ,
Atypical parkinsonism in the Caribbean island of Guadeloupe: Etiological role of the mitochondrial complex I inhibitor annonacin, Movement Disorders, vol.48, issue.15, pp.2122-2128, 2008. ,
DOI : 10.1002/mds.22300
The many faces of ??-synuclein: from structure and toxicity to therapeutic target, Nature Reviews Neuroscience, vol.418, issue.1, pp.38-48, 2013. ,
DOI : 10.1038/nrn3406
Systems Approach to Neurodegenerative Disease Biomarker Discovery, Annual Review of Pharmacology and Toxicology, vol.54, issue.1, pp.457-481, 2014. ,
DOI : 10.1146/annurev-pharmtox-011613-135928
Gaucher Disease Glucocerebrosidase and ??-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies, Cell, vol.146, issue.1, pp.37-52, 2011. ,
DOI : 10.1016/j.cell.2011.06.001
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells, Brain, vol.137, issue.5, pp.1481-1495, 2014. ,
DOI : 10.1093/brain/awu020
Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture, Journal of Neuroscience Research, vol.17, issue.4, pp.428-435, 1990. ,
DOI : 10.1002/jnr.490260405
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease, The FASEB Journal, vol.27, issue.9, pp.3414-3423, 2013. ,
DOI : 10.1096/fj.12-220418
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1271, issue.1, pp.265-274, 1995. ,
DOI : 10.1016/0925-4439(95)00038-6
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies, Acta Neuropathologica Communications, vol.1, issue.1, p.11, 2013. ,
DOI : 10.1016/S1474-4422(09)70238-8
Reduced glucocerebrosidase is associated with increased ??-synuclein in sporadic Parkinson's disease, Brain, vol.137, issue.3, pp.834-882, 2014. ,
DOI : 10.1093/brain/awt367
Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein ??-Synuclein, Journal of Biological Chemistry, vol.286, issue.23, pp.20710-20736, 2011. ,
DOI : 10.1074/jbc.M110.213538
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin, PLoS Biology, vol.126, issue.1, 2010. ,
DOI : 10.1371/journal.pbio.1000298.s013
Mutant ??-Synuclein Enhances Firing Frequencies in Dopamine Substantia Nigra Neurons by Oxidative Impairment of A-Type Potassium Channels, Journal of Neuroscience, vol.34, issue.41, pp.13586-99, 2014. ,
DOI : 10.1523/JNEUROSCI.5069-13.2014
A new pathway for mitochondrial quality control: mitochondrial-derived vesicles, The EMBO Journal, vol.33, issue.19, pp.2142-2156, 2014. ,
DOI : 10.15252/embj.201488104
Origin and functional consequences of the complex I defect in Parkinson's disease, Ann. Neurol, vol.40, pp.663-671, 1996. ,
A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson???s disease, Nature Communications, vol.18, p.5181, 2014. ,
DOI : 10.1006/neur.1996.0041
Mitochondrial Regulation of Cell Death, Cold Spring Harbor Perspectives in Biology, vol.5, issue.9, p.8706, 2013. ,
DOI : 10.1101/cshperspect.a008706
Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin, The Journal of Cell Biology, vol.19, issue.7, 2010. ,
DOI : 10.1083/jcb.201007013.dv
VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for ??-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease, Journal of Neuroscience, vol.35, issue.29, pp.10613-10628, 2015. ,
DOI : 10.1523/JNEUROSCI.0042-15.2015
Differential effects of nicotine on the activity of substantia nigra and ventral tegmental area dopaminergic neurons in vitro, Acta Neurobiol. Exp, vol.64, pp.119-130, 2004. ,
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy, Human Molecular Genetics, vol.20, issue.1, pp.40-50, 2011. ,
DOI : 10.1093/hmg/ddq430
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration, Human Molecular Genetics, vol.23, issue.17, pp.4621-4238, 2014. ,
DOI : 10.1093/hmg/ddu178
Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology, Journal of Neurochemistry, vol.89, 2015. ,
DOI : 10.1111/jnc.13449
Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death, Human Molecular Genetics, vol.20, issue.18, pp.3565-3577, 2011. ,
DOI : 10.1093/hmg/ddr274
Lysosomal dysfunction in neurodegeneration, Autophagy, vol.8, issue.6, pp.987-988, 2012. ,
DOI : 10.4161/auto.20256
The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease, Neurobiology of Disease, vol.51, pp.43-55, 2013. ,
DOI : 10.1016/j.nbd.2012.05.015
Membrane Permeabilization by Oligomeric ??-Synuclein: In Search of the Mechanism, PLoS ONE, vol.28, issue.12, 2010. ,
DOI : 10.1371/journal.pone.0014292.s001
Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions, Neuron, vol.47, issue.3, pp.365-378, 2005. ,
DOI : 10.1016/j.neuron.2005.06.018
VPS35 Mutations in Parkinson Disease, The American Journal of Human Genetics, vol.89, issue.1, pp.162-169, 2011. ,
DOI : 10.1016/j.ajhg.2011.06.001
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy, Proceedings of the National Academy of Sciences, vol.107, issue.1, pp.378-383, 2010. ,
DOI : 10.1073/pnas.0911187107
PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility, Cell, vol.147, issue.4, pp.893-906, 2011. ,
DOI : 10.1016/j.cell.2011.10.018
In vivo demonstration that alpha-synuclein oligomers are toxic, Proc. Natl. Acad. Sci. U S A, pp.4194-4199, 2011. ,
??-Synuclein impairs macroautophagy: implications for Parkinson???s disease, The Journal of Cell Biology, vol.190, issue.6, pp.1023-1037, 2010. ,
DOI : 10.1083/jcb.201003122.dv
Differential expression of the smallconductance , calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons, J Neurosci, vol.21, pp.3443-3456, 2001. ,
Abberant ??-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy, PLoS ONE, vol.22, issue.5, p.5515, 2009. ,
DOI : 10.1371/journal.pone.0005515.s005
Membrane-bound ??-synuclein interacts with glucocerebrosidase and inhibits enzyme activity, Molecular Genetics and Metabolism, vol.108, issue.1, pp.56-64, 2013. ,
DOI : 10.1016/j.ymgme.2012.11.010
Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons, NeuroToxicology, vol.45, pp.1-11, 2014. ,
DOI : 10.1016/j.neuro.2014.08.009
Mitochondrial Fission, Fusion, and Stress, Science, vol.337, issue.6098, pp.1062-1065, 2012. ,
DOI : 10.1126/science.1219855
Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans, PLoS ONE, vol.27, issue.8, 2011. ,
DOI : 10.1371/journal.pone.0022354.s008
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease, The American Journal of Human Genetics, vol.89, issue.1, pp.168-175, 2011. ,
DOI : 10.1016/j.ajhg.2011.06.008